期刊文献+

JNK MAPK信号通路在食管癌细胞系Eca-109细胞中的作用机制 被引量:2

Mechanism of JNK1/2 MAPK signaling pathway in human esophageal cancer cell line Eca-109
原文传递
导出
摘要 目的探讨c-jun氨基末端激酶1/2(c-jun N-teuninal kinase,JNK 1/2)信号通路在食管癌细胞系Eca-109细胞中的作用。方法体外培养Eca-109细胞,以特异性JNK信号转导通路抑制剂SP600125处理Eca-109细胞;RT-PCR的方法检测JNK1和JNK2基因的表达,Western blot法检测JNK和p-JNK蛋白的表达,MTT(3-(4,5-Dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide)法检测细胞增殖,流式细胞术检测细胞凋亡。结果 Eca-109细胞经SP600125分别处理24h和48 h后,分别与对照组比较,JNK1 mRNA的表达无统计学差异(均P>0.05),JNK2 mRNA的表达也无统计学差异(均P>0.05),但活化的JNK即P-JNK1/2蛋白的表达显著减少,细胞的增殖显著被抑制,细胞的凋亡率有统计学差异(均P<0.05)。结论 JNK信号通路可能在Eca-109细胞的发生发展中发挥重要作用。 Objective To explore mechanism of c-Jun N-teuninal kinase(JNK1/2) signaling pathway in human esophageal cancer cell line Eca-109.Methods Eca-109 cells were cultured in vitro and then treated with SP600125,a specific JNK inhibitor,and mRNA expression of JNK1/2 was examined by RT-PCR;the expression of p-JNK protein was detected by western blot.MTT was used to perform cell growth inhibitory rate.Flow cytometry was taken to evaluate apoptosis at a very early stage.Results After being treated by SP600125 with 24 h and 48 h,the mRNA expression of JNK1 displayed no statistical significance(both P0.05),the mRNA expression of JNK2 showed no statistical significance(both P0.05);but protein expression of p-JNK1/2 was remarkably reduced by SP600125 as well as the apoptosis rate and cell growth inhibitory rate in the human esophageal cancer cell line Eca-109 cells as compared with control group(both P0.05).Conclusions JNK signaling pathway may play an important role in the carcinogenesis of Eca-109 cells.
出处 《疾病预防控制通报》 2011年第5期1-4,共4页 Bulletin of Disease Control & Prevention(China)
基金 国家自然科学基金(30860097) 新疆维吾尔自治区科技援疆计划(201191157) 新疆医科大学第一附属医院科研奖励基金(2011YFY17)
关键词 c-jun氨基末端激酶1/2 SP600125 食管癌 细胞凋亡 增殖 c-jun N-teuninal kinase(JNK 1/2) Specific JNK inhibitor(SP600125) Esophageal cancer Apoptosis Proliferation
  • 相关文献

参考文献9

  • 1Madhumita Das,David S Garlick,Dale L Greiner,et al.The role of JNK in the development of hepatocellular carcinoma. Genes and Development . 2011
  • 2Aleksi Lahti,Outi Sareila,Hannu Kankaanranta,et al.Inhi-bition of p38mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity:Implication in inducible ni-tric oxide synthase expression. BMC Pharmacology . 2006
  • 3Hengning Ke,Rebecca Harris,Jonathan L,et al.The c-Jun NH2-terminal kinase2plays a dominant role in human epi-dermal neoplasia. Cancer Research . 2010
  • 4Hui Lijian,Kurt Zatloukal,Harald Scheuch,et al.Prolifera-tion of human HCC cells and chemically induced mouse liv-er cancers requires JNK1-dependent p21downregulation. The Journal of Clinical Investigation . 2008
  • 5Nateri A S,Spencer-Dene B,Behrens A.Interaction ofphosphorylated c-Jun with TCF4 regulates intestinal cancerdevelopment. Nature . 2005
  • 6LE Heasley,SY Han.JNK regulation of oncogenesis. Molecules and Cells . 2006
  • 7Winn RA,Marek L,Han SY,et al.Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. Journal of Biological Chemistry . 2005
  • 8Davis R J.Signal transduction by the JNK group of MAP kinases. Cell . 2000
  • 9She Q B,Chen N,Bode A M,Flavell R A,Dong Z.Deficiency of c-Jun-NH (2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research . 2002

同被引文献24

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部